CLINICAL_TRIALS
trial_result
· 2016-06-02
Clinical Trial Update: Tecemotide (L-BLP25) in Rectal Cancer [Phase 2]
Summary
Phase 2 trial update of Tecemotide (L-BLP25) in rectal cancer; results have been posted after study completion.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Merck KGaA, Darmstadt, Germany | Conditions: Rectal Cancer | Phase 2 | Status: COMPLETED | Results posted: 2016-06-02